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Mast cells have been shown to release extracellular vesicles (EVs) in vitro. However,
EV-mediated mast cell communication in vivo remains unexplored. Primary mast
cells fromGFP-transgenic and wild typemice, were grown in the presence or absence
of lipopolysaccharide (LPS), and the secreted EVs were separated from the condi-
tioned media. Mast cell-derived EVs were next cultured with LPS-naïve mast cells,
and the induction of TNF-α expression was monitored. In addition, primary mast
cells were seeded in diffusion chambers that were implanted into the peritoneal cavi-
ties ofmice. Diffusion chambers enabled the release of GFP+mast cell-derived EVs in
vivo into the peritoneal cavity. Peritoneal lavage cells were assessed for the uptake of
GFP+ EVs and for TNF-α production. In vitro, LPS-stimulatedmast cell-derived EVs
were efficiently taken up by non-stimulated mast cells, and induced TNF-α expres-
sion in a TLR4, JNK and P38 MAPK dependent manner. In vivo, using implanted
diffusion chambers, we confirmed the release and transmission of mast cell-derived
EVs to other mast cells with subsequent induction of TNF-α expression. These data
show an EV-mediated spreading of pro-inflammatory response between mast cells,
and provide the first in vivo evidence for the biological role of mast cell-derived EVs.
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 INTRODUCTION
Mast cells (MCs) are important players of the immune system. Although they are best known for their role in hypersensitivity
reactions, they are also important participants of the immune response against pathogens. Similarly to dendritic cells (DCs)
and macrophages, MCs express toll like receptors (TLRs) including TLR2, TLR3, TLR4, TLR6, TLR7 and TLR9 that recognize
invading pathogens (Marshall, King, & McCurdy, 2003). TLR4 dependent stimulation of MCs with lipopolysaccharide (LPS)
induces TNF-α, IL-1b, IL-6 and IL-13 but not IL-4 or IL-5 secretion (Supajatura et al., 2002).We and others have shown thatMCs
play a crucial role in the clearance of bacterial infections such as Bordetella pertussis or Escherichia coli (Mielcarek et al., 2001;
Wierzbicki & Brzezinska-Blaszczyk, 2009) by secretion of TNF-α (Vukman et al., 2012; Vukman, Ravida, Aldridge, & O’Neill,
2013).
Nowadays, it is obvious that beside cytokines,MCs also secrete extracellular vesicles (EVs), conveyors ofmessages in cell-to-cell
communication (Ekstrom et al., 2012; Stassen, Hartmann, Delgado, Dehmel, & Braun, 2019; Vukman, Forsonits, Oszvald, Toth, &
Buzas, 2017).MC-derived EVs have been shown to induce bothTh1 andTh2 immune responses (Skokos et al., 2001) and influence
the function of other immune cells such as DCs (Skokos et al., 2003) or B-cells (Mion et al., 2014; Skokos et al., 2001). During
infection, MCs produce EVs that contain increased levels of ICAM1, TGF-β and TNF-precursors, thus, might influence the
function other immune cells during inflammation (Al-Nedawi, Szemraj, & Cierniewski, 2005; Hugle, Hogan,White, & van Laar,
2011; Nakae et al., 2006). There is an increasing number of evidence that EVs are also involved in the MC-MC communication.
MC-derived EVs contain functional mRNA, shuttle it to other MCs cells and alter their function (Eldh et al., 2010; Valadi et al.,
2007).
AlthoughMCs have been suggested to serve as conductor cells in the immune response, they are present in tissues in a surpris-
ingly low number. Here we addressed the question whether EVs could spread MC-derived messages upon sensing the bacterial
ligand LPS thus compensating for the low frequency of MCs. The data presented in this report provide evidence for both in vitro
and in vivo spread of a proinflammatory response by MC-derived EVs.
 MATERIALS ANDMETHODS
. Mice
C57BL/6 and GFP-expressing C57BL/6-Tg(UBC-GFP)30Scha/J mice (designated in this manuscript as “GFP mice”) were both
purchased from the Jackson Laboratory, and were bred in the specific pathogen-free animal facility at the Department of Genet-
ics, Cell- and Immunobiology, Semmelweis University. Ethics approval for mouse experiments was obtained from local ethical
committee (PE/EA/561-7/2019, PE/EA/562-7/2019).
. Differentiation and expansion of bone marrow-derived MCs (BMMCs) and peritoneal
cell-derived cultured MCs (PCMCs)
BMMCs were generated from femoral and tibial bone marrow cells of C57BL/6 and GFP mice. Cells were cultured in complete
IMDM (Gibco) in the presence of 10% heat-inactivated foetal bovine serum (FBS, Gibco, Life Technologies), 100 u/ml peni-
cillin/streptomycin (Sigma-Aldrich). As a source of murine IL-3, cells were grown in 30%WEHI-3 conditioned IMDMmedium
(TIB-68; American Type Culture Collection, Manassas, VA, USA) for 4 weeks (Vukman, Adams, Metz, Maurer, & O’Neill, 2013).
PCMCs were obtained as described previously (Vukman et al., 2013). Briefly, C57BL/6 mice were injected intraperitoneally with
10 ml sterile PBS. The peritoneal lavage cells were cultured in RPMI-1640 medium, supplemented with 10% FCS and 100 u/ml
penicillin/streptomycin, l-glutamine (2 mM; Sigma-Aldrich), 10 ng/ml mouse rIL-3 (Calbiochem,Merck), and 30 ng/ml recom-
binant mouse stem cell factor (Sigma-Aldrich) at 37◦C. Forty-eight hours later, non-adherent cells were discarded and fresh
culture medium was added for a further 7 days. In both MC preparations, > 95% of the total cells were identified as MCs on the
basis of cell-surface expressions of c-Kit (Clone 2B8; eBioscience) and FcɛRI (Clone MAR1; eBioscience) and Kimura staining
(0.05% toluidine blue solution + saturated saponin solution + phosphate buffer pH6.4) (Kimura, Moritani, & Tanizaki, 1973).
Cell number and viability were monitored using trypan blue staining (Sigma-Aldrich) and by flow cytometry using propidium
iodide, annexin V-APC, 7AAD or TO-Pro3 as described by the manufacturer (ThermoFischer).
β-Hexosaminidase release from MCs was measured in a 96 well plate colorimetric assay as described previously (Vukman
et al., 2012). Briefly, BMMCs or PCMCs were washed twice with PBS, resuspended in Tyrode’s buffer and seeded in a 96-well
round-bottom plate at a density of 4 × 105 cells/200 μl followed by stimulation with stimulants, LPS (100 ng/ml ), A23187 (0.5
μM) or PBS for 1 h at 37◦C. Cell pellets were solubilized in Tyrode’s buffer supplemented with 1% Triton X-100, and the cell
lysates and supernatants were incubated separately with p-nitrophenyl-N-acetil-b-d-glucosamide (p-NAG) substrate for 1 h at
37◦C. The production of b-hexosaminidase-mediated p-nitrophenol was terminated by adding 150 μl 0.2 M glycine (pH10.7)
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and quantified by absorbance at 405 nm with an ELISA plate reader. The percentage of β-hexosaminidase release indicating the
extent of degranulation was calculated as the ratio of p-nitrophenol absorbance in the supernatants and the sum of absorbance
in the supernatant and cell lysates.
. EV separation from conditioned cell culture medium
BMMCs (20 × 106 cells) or PCMCs (2 × 106 cells) were incubated for 24 h in EV-depleted complete, IL-3 containing MC culture
medium as described above in the presence or absence of 100 ng/ml LPS (Sigma). For co-culture and in vivo studies, after 1 h
incubation with LPS, cells were washed twice and were placed in fresh medium to avoid the carry-over of LPS in the released EV
populations. As positive control of induction of EV release, 0.5 μMA23187 (Sigma) was used, as upon degranulation,MCs secrete
huge amount of EVs as described previously (Amanda Carroll-Portillo, Cambi, Lidke, & Wilson, 2012). EVs were separated
with minor modifications of the method described previously by us (Osteikoetxea et al., 2015). Briefly, cells were removed by
centrifugation at 300 × g for 10 min at room temperature (RT), and then the supernatant was filtered by gravity through a 5 μm
filter (Millipore, Billerica,MA). The filtratewas next submitted to a 2,000× g centrifugation for 20min at 4◦C to pellet lEVs (lEVs)
(Avanti J-XP26 centrifuge, JA 25.15 rotor, Beckman Coulter Inc.). Afterwards, the supernatant was filtered by gravity through a
0.8 μm filter (Millipore) to remove any remaining lEVs, and centrifuged at 12,500 × g for 40 min at 4◦C to pellet medium sized
EVs (mEVs) (Avanti J-XP26 centrifuge, JA 25.15 rotor, Beckman Coulter Inc.). Finally, the supernatant was filtered by gravity
through a 0.22 μm filter (Millipore) and ultracentrifuged in an Optima MAX-XP bench top ultracentrifuge with MLA-55 rotor
(Beckman Coulter Inc.) at 100,000 × g for 70 min at 4◦C to pellet small EVs (sEVs). Each EV pellet was re-suspended once
in phosphate-buffer-saline (PBS), and re-centrifuged under the same conditions as what has been used originally for pelleting.
Three different, size-based subpopulations were isolated including lEVs, mEVs and sEVs by the above combination of gravity
driven filtration and differential centrifugation.
. Mast cell – mast cell co-culture
BMMCs from wild type C57BL/6 mice and GFP-BMMCs or PKH67 (SIGMA)-stained BMMCs were either cultured alone or
were co-cultured at 1:1 ratio in EV-free complete medium (see above) in the presence or absence of LPS (100 ng/ml). A23187 (0.5
μM) was used as positive control. After 24 h, fluorescence intensity (GFP) was measured by flow cytometry. Mean fluorescence
intensity (MFI) of unstained wild type cells were calculated using FlowJo after exclusion of GFP-BMMCs by gating. Results were
normalized toMFI values of unstainedwild type cells cultured alone. Results were confirmed by confocalmicroscopy (Leica SP8).
. Exposure of MCs to EVs secreted by unstimulated or LPS-stimulated MCs
GFP-BMMCs and PKH67-stained BMMCs were cultured in complete medium supplemented with EV-depleted serum in the
presence or absence of LPS (100 ng/ml) in the first hour. After washing, cells were grown for 24 h in EV-depleted complete
medium. A23187 (0.5 μM) and PBS were used as positive and negative controls, respectively. EVs were separated from the
conditioned medium as described above. Unstained non-stimulated BMMCs derived from C57BL/6 mice and were cultured
in (i) EV-free medium (control), (ii) conditioned medium (SN), (iii) EV-depleted conditioned medium (EV-dep SN), (iv) EV-
reconstitutedmedium (EV-rec SN) or (v) non-conditionedmedium supplemented by separated EVs (EV).We kept the EV donor
MC numbers the same as the acceptor ones. Fluorescence intensity was measured by flow cytometry. EV uptake was monitored
by fluorescent and confocal microscopy (Nikon Eclipse 80i). TNF-α was measured by commercially available ELISA kit (R&D
Systems).
In inhibition experiments, cells were treated with TAK242 (0.2 μM), dynasore (80 μM) or cytochalasin D (10 μg/ml) prior
to adding separated EVs to cells. To exclude a potential LPS carry-over, EVs from unstimulated BMMCs were incubated in 100
ng/ml LPS for 2 h, and we used GW4869 (10 μM), a neutral sphingomyelinase inhibitor to block small EV generation, 30 min
before LPS stimulation of donor cells. Then EVs were submitted to washing by PBS before addition to naïve (non-stimulated)
BMMCs. The inhibitory effect of GW4869 was monitored by NTA (as manufacturer protocol) on separated sEVs.
. Cell-based ELISA measurements
To investigate if exposure to EVs induced the activation ofMAPK-signalling, BMMCswere cultured for 24 h in EV-free complete
medium in the presence of isolated EVs derived from LPS-stimulated and unstimulated BMMCs (donor cell numbers were the
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same as naïve MC numbers). Cells were washed twice, lysed and investigated for phosphorylation of ERK1/2, JNK and P38 by
RayBio Cell-based phosphorylation ELISA kits following the protocol of the manufacturers (RayBiotech PEL-Erk-T202-T-01,
PEL-JNK-T183-T-1 and PEL-P38-T180-T-1).
. Determination of size distribution and concentration of EVs
Size distribution and concentration of MC-derived EVs in the conditioned medium or in the case of separated EVs were
determined by tuneable resistive pulse sensing (TRPS) using a qNano instrument (IZON Science) as we described previously
(Osteikoetxea et al., 2015). Briefly, EV samples from 10 ml supernatant of 20 × 106 cells were diluted in 0.2 μm-filtered 0.01% Tri-
ton X-100 (Sigma) containing PBS (in 1:50 and 1:100). At least 500 particles were counted using 3–5 mbar pressure using NP200,
NP400, NP800 and NP2000 nanopore membranes. Calibration was performed with known concentration of beads CPC100,
CPC200, CPC300, CPC800, CPC1000 and CPC2000 (diluted as suggested by IZON user manual) in 0.2 μm-filtered PBS. Results
were evaluated using the IZON Control Suite 3.2 software.
In some experiments, nanoparticle tracking analysis (NTA) was also used. Briefly, measurements were performed on a
ZetaView PMX120 instrument (Particle Metrix, Germany). Separated sEV samples were diluted in PBS to achieve the opti-
mal concentration (50–200 particles/frame). Each sample was measured in 11 positions (2 cycles per position) and the acquired
video has been used for particle size and concentration analysis. The following camera parameters were used: shutter speed-100,
sensitivity-80, frame rate-30. The recordings were performed at 25C.
. Detection of EVs by transmission electron microscopy (TEM)
MC-derived EVs were examined by TEM using a protocol we described previously (Visnovitz et al., 2019). For phosphotungstic
acid contrasting, samples were fixed with 4% glutaraldehyde onto the surface of 300 mesh formvar-coated grids and contrasted
with 2% phosphotungstic acid. For immune electron microscopy, samples were fixed with 4% paraformaldehyde onto formvar-
coated grids and labelled with polyclonal rabbit anti-CD63 IgG (H-193, sc-15363, Santa Cruz Biotechnology) and c-Kit (Clone
2B8; eBioscience). Polyclonal goat anti-rabbit IgG/10 nm gold pre-adsorbed (Abcam) or polyclonal goat anti-mouse IgG/5 nm
gold pre-adsorbed (Sigma) were used as secondary antibodies. For background contrasting, 2% phosphotungstic acid was used
after permanent fixation by 2% glutaraldehyde. Samples were examined by a JEOL 1011 transmission electron microscope.
. Determination of protein content of EV preparations
Protein concentration of EV preparations was determined with the Micro BCA Protein Assay kit (ThermoFisher) according
to the instructions of the manufacturer. Briefly, EVs were diluted 5–10 times and were lysed with 0.5% Triton X-100 (Sigma)
and 0.5% SDS (Sigma). Colour was developed for 1 h at 60◦C and absorbance was measured at 562 nm by NanoDrop NP-1000
(ThermoFisher).
. Determination of the lipid content of EVs by the SPV assay
Lipid content of MC-derived EVs was measured using the SPV assay protocol that we described previously (Visnovitz et al.,
2019). In brief, 200 μl of 96% sulphuric acid (Molar Chemicals) was added to 40 μl EVs suspended in PBS. EVs were incubated
at 90◦C (AccuBlock digital dry batch, Labnet) for 20 min. After cooling down to room temperature, 120 μl of phospho-vanillin
reagent (1 mg/ml vanillin (Sigma) in 17% phosphoric acid (Sigma)) was added. Colour reaction was measured on 96 well plate
(ThermoFisher) at 540 nm (plate reader, Multiskan MS, Labsystems).
. Characterization of EVs by flow cytometry
EVs were incubated with the affinity reagents annexin V (APC, PE, FITC, BD Bioscience), lactadherin (Haematologic Tech-
nologies, labelled with Cy5 Fast Conjugation Kit, Abcam), PKH67 (FITC, Sigma-Aldrich) and antibodies including anti-CD9
Ab (PE, FITC, ThermoFisher), anti-CD63 (APC, PE, eBioscience) anti-CD81 (FITC, ThermoFisher), FcɛRI (PE, FITC, eBio-
science), CD117 (APC, PE, eBioscience) or appropriate IgG isotype controls (mouse IgG1, IgG2, IgG2b isotype control (BD Bio-
science, Biolegend and SONY). LEVs were also stained by propidium iodide, annexin V, lactadherin and caspase-3/7 (cellEvent
Caspase-3/7 Green Detection Reagent; Invitrogen) to check their apoptotic features. Antibody dilution was selected based on
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titration for each batch of reagents or as advised by the suppliers. Samples were incubated with antibodies for 1 h at 4◦C in the
dark in 50 μl 2% EV-depleted foetal bovine serum (Gibco) in PBS followed by washing steps and dilution to 300 μl prior to
measurement. Autofluorescence, fluorescence of the affinity reagents and the fluorochrome-labelled antibodies in the absence of
EVs were also determined, and in the case of large and medium EVs (mEVs), 0.1% Triton X-100 lysis was used as a control to
disrupt EV signals as we described earlier (Gyorgy et al., 2011; Osteikoetxea et al., 2015). Isolated sEVs were coupled to 4 μmalde-
hyde/sulphate latex beads (Life Technologies) and blocked with 100mM glycine for 2 h followed by incubation with 1% bovine
serum albumin in PBS overnight. In multicolour experiments, unstained, single-stained, and fluorescence-minus-one controls
were also used. In the case of cells, mAb binding was analysed by flow cytometry (FACSCalibur; BD Biosciences and a CytoFLEX
S V4-B2-Y4-R3 Flow Cytometer; Beckman Coulter) in the presence of DNase to avoid aggregation. FlowJo (Treestar) was used
to analyse flow cytometry data. An example for gating prior to analysis of results is demonstrated in Figure S1.
. Characterization of EVs byWestern blot
Total protein was extracted from small, medium and lEVs derived from 20 × 106 BMMCs (unstimulated, 100 ng/ml LPS and
0.5 μM A23187 stimulated), by sonication. Protease and phosphatase inhibitor cocktails were added (Sigma-Aldrich). Protein
samples (10–40 μg) and pre-stained protein markers (26634, Spectra Multicolor Broad Range Protein Ladder) were separated
by SDS-PAGE and blotted onto 0.2 μm Immun-Blot PVDF membranes (Bio-Rad). Membranes were stained according to stan-
dardWestern blot protocol using anti-TSG101 (T5701, Sigma-Aldrich), anti-Alix (ab186429, Sigma-Aldrich, Dublin, Ireland) and
anti-rabbit Abs (ab205718, Sigma-Aldrich). Proteins were visualized with a chemiluminescent HRP substrate (32106, Thermo
Scientific) and recorded by Gel documentation system (CHEMI Premium, VWR).
. OptiPrep density gradient of purified EV populations and MC conditioned media
A discontinuous iodixanol gradient was used as described by Van Deun et al (2014) with some modifications. Solutions of 5, 10,
20 and 40% iodixanol were prepared and the gradient was formed by layering 1 ml of each solution on top of each other in a 5 ml
open top tube. Half ml of conditioned medium was overlaid onto the top of the gradient in the case of PCMCs, while separated
EV samples (BMMCs) were ultracentrifuged from bottom up. Gradients were then centrifuged for 18 h at 100,000 × g, at 4◦C
in an Optima MAX-XP bench top ultracentrifuge with MLS-50 rotor (Beckman Coulter Inc.). Gradient fractions of 0.5 ml were
collected from the top of the gradient and washed once in PBS (sEVs: 100,000 × g - 3h, mEVs: 12,500 × g - 1.5h, lEVs: 2000 × g
– 40 min). In the case of conditioned medium samples, EV populations were separated from all fractions as described above. To
estimate the density of fractions, samples were measured by a precision analytical weight and density was calculated.
. Mass spectrometry (MS) characterization of medium size EVs
EV pellets were re-suspended in 20μl water. Samples were subjected to repeated freeze-thaw cycles and digestion as described
previously (Turiak, Ozohanics, Marino, Drahos, & Vekey, 2011). The peptide digest was analysed using a Bruker Maxis II Q-TOF
instrument with CaptiveSpray nanoBooster ionization source. Peptides were separated online using a 25 cm Acclaim Pepmap
RSLCnanoHPLC column on theDionexUltimate 3000Nano LC System.Data were evaluatedwith Scaffold (Proteome Software,
Inc., Portland, OR 97219, USA).
. In vivo studies
BMMCs from GFP mice were incubated for 1h in the presence or absence of LPS (100 ng/ml ) and washed 2 times with PBS
to avoid LPS contamination. For diffusion chamber experiments, commercially available EMD Millipore’s Diffusion Cham-
ber Kits (PR00 014 01, Merck) were used. The diffusion chambers were assembled with two membrane filters (GSWP01300
or GVWP01300, both having 5 μm pore size) supplied in the kit using a 100% silicone glue (F.BS, Material Chemical Company,
Budapest) that contained no antifungal-ingredients and acetic acid in traces only. Chambers were then dried and sterilized with
ultraviolet light. After sterilization, they were washed in sterile PBS with 5% Pen/Strep overnight. 1 million MCs were injected
through the opening of the chamber, and the opening was plugged with a piece of the plastic rod supplied in the kit. Empty
(mock-operated) andMC-containing chambers were then implanted into the peritoneal cavities of C57BL/6mice for 24 h before
removing them surgically (Figure S2). In additional experiments, EVs separated from the conditionedmediumof LPS-stimulated
and unstimulated BMMCs were injected intraperitoneally twice in 24 h (at 0 h and at 22th h). For each injection, separated EVs
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from the conditionedmedium of 106 BMMCswere used. To exclude the possibility of LPS contamination, in control experiments
mice were also injected intraperitoneally by 100 ng LPS.
After 24 h, mice were sacrificed, and peritoneal cells were collected by peritoneal lavage. Peritoneal cells were counted and
assessed by trypan blue staining. MC numbers were determined using Kimura staining by microscope and by flow cytometry
using two pan-MC markers CD117 (c-Kit) and FcɛRI. Intracellular TNF-α was also measured by flow cytometry after Brefeldin
A treatment (3 μg/ml for 1h). Cells were also examined under a confocal microscope (Leica SP8). Cells retrieved from removed
diffusion chambers were submitted to enumeration and viability test using trypan blue staining. Uptake of GFP-EVs by other cell
typeswere tested bymulticolour flow cytometry similarly towhat has been described forMCs.Used antibodieswere: CD4 (Clone:
RM4-5, Biolegend), CD8 (Clone: 5H10, Invitrogen), CD45R (Clone: RA3-6B2, Biolegend), CD11b (Clone: M1/70, Biolegend),
CD20 (Clone: SA 275A11, Biolegend), FcɛRI (Clone: MAR1, eBioscience) and CD117 (Clone: 2B8, eBioscience). In multicolour
experiments, unstained, single stained and Fluorescence Minus One (FMO) controls were also used.
. Statistical analysis
All data were tested for normality prior to statistical analysis by origin 6.1 software (OriginLab Corporation, Northhampton,MA,
USA) and Prism (GraphPad Software, Sandiego, CA, USA). For comparisons between two groups, Student’s t-test was used. For
comparison of multiple groups, we used One-way ANOVA. In all tests, P < 0.05 was considered significant.
 RESULTS
. Cellular uptake of MC-derived EVs
To test if MCs were able to exchange cytoplasmic and membrane components between each other, we used two different pri-
mary cell culture systems: BMMCs and PCMCs derived from wild type or GFP-expressing C57BL/6 mice (GFP-MC). Viabil-
ity, morphology, purity and integrity was checked for every experiment, and cells were only used if viability was above 99%,
and purity was above 99% for BMMCs and 95% for PCMCs, while the rate of degranulation was 50 ± 10% (as accepted)
(Figure 1).
When GFP-MCs and wild type MCs were co-cultured for 24 h in the presence of (i) PBS, (ii) LPS or (iii) A23187, the fluo-
rescence intensity of wild type MCs increased by 30 ± 23%, 27 ± 17% and 117 ± 88%, respectively (Figure 2a,c). To test if MCs
transferred not only cytosolic proteins (GFP) but alsomembrane components, we also co-cultured PKH67-stained and unstained
MCs. In the unstained MCs, fluorescence intensity increased by 81 ± 20%, 81 ± 18% and 78 ± 14%, respectively, (Figure 2b,d)
upon culture in the presence of PKH67 stained cells. By confocal microscopy we also confirmed in this experimental system
that GFP-MC-derived EVs were taken up by wild type MCs and are found inside the cell after 24 h (Figure 2e-h, Supplementary
video 1).
. LPS stimulation induces secretion of MC-derived EVs with similar morphology to those
derived from unstimulated MCs
These results raised the possibility that cytoplasm and membrane exchange could take place by EV transfer between cells. Thus,
we analysed particles in the conditioned medium of PBS-, LPS- or A23187-stimulated BMMCs. We found three size-based par-
ticle populations when measuring with qNano (NP200, NP400 and NP2000) including small particles with average diameter
of 193 ± 6 nm, medium-size particles of 317 ± 13 nm and large particles of 1214 ± 25 nm. There was no size difference between
particles secreted in the presence of PBS, LPS or A23187 using t test. Concentrations of all three size-based populations of par-
ticles (derived from the same amount of cells) from PBS or LPS-stimulated MCs showed no significant difference (Figure 2i-k),
while concentration of medium sized particles (measured with membrane NP400) derived from A23187-stimulated BMMCs
(positive control) were slightly higher than those in the PBS and LPS groups (P ≤ 0.05, Figure 2j). As TRPS cannot distin-
guish membrane coated particles from protein aggregates, this increase may be the result of extracellular granules, as a result of
degranulation.
Upon stimulation, MCs secrete pre-synthetized, stored granules (degranulation) as well as they can release soluble mediators
or EVs (Vukman et al., 2017). Therefore, in our case it was crucial to assess if the particles derived from BMMCs or PCMCs were
granules or membrane enclosed EVs. To this end, we separated particles with differential centrifugation. We got three particle
populations:, small ones after 100,000 × g, medium-sized ones after 12,500 × g, and large ones after 2,000 × g centrifugation with
average diameter of 105 ± 3 nm (Figure 3a), 309 ± 13 nm (Figure 3b) and 1811 ± 59 nm (Figure 3c), respectively. Large particle
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F IGURE  Identification of BMMCs and PCMCs. Mast cell nature was confirmed by showing the degranulation capacity of BMMCs (a) and PCMCs (b)
with β-hexosaminidase assay in the presence of LPS (100 ng/ml ) and A23187 (0.5 μM). Cell purity was assessed by flow cytometry on the 4th week of mast
cell differentiation (BMMC, c) or on 10th day of culture (PCMC, d) by flow cytometry, based on FcɛRI and c-Kit positivity. BMMCs from C57BL/6 mice were
studied by phase contrast microscopy (e), while GFP-BMMCs from C57BL-GFP mice were analysed by fluorescent microscopy (f). Cellular purity was also
checked by Kimura staining (g). The optimal concentration of LPS (h) and incubation time (i) were chosen based on TNF-α secretion measured by ELISA.
Graphs show the mean and SD of three biological replicates, where one point indicates the average of three technical replicates (n = 3, *P ≤ 0.05, **P ≤ 0.01
t test)
diameters differed from those measured directly from conditioned medium (P ≤ 0.001, ANOVA), probably because TRPS does
not distinguish EVs and protein aggregates.
To confirm our TRPS results, we also analysed the separated particles by TEM. Particles from all separations showed the
expected EV morphology and their size distribution was close to what has been seen in TRPS except for large structures which
collapsed during sample preparation (Figure S3). We also confirmed that these structures positive for CD63 and the MC pan
marker c-Kit by immune-gold TEM (Figure 3d-l) therefore, we concluded that they were EVs.
Looking at EV markers by flow cytometry, all three (large, medium and small) size-based populations from PBS, LPS- or
A23187-stimulated BMMCswere positive for CD63, CD9 but only small vesicles were positive for CD81. All samples were positive
for fluorochrome-labelled PKH67 and slightly for lactadherin (5.7± 3.2), but only large vesicles showed 9.5± 0.5 % positivity for
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F IGURE  Uptake of MC-derived EVs by MCs. Non-fluorescent BMMCs from C57BL/6 mice were co-cultured with GFP-BMMCs with cytoplasmic
fluorescence, derived from C57BL-GFP mice (a, c) or PKH-stained BMMC with fluorescent plasma membrane (b, d) in the presence of PBS or 100 ng/ml LPS.
A23187 (0.5 μM) was used as positive control. For negative control, unstained C57BL/6-derived BMMCs were used (a and b, grey histograms). Scatter plots show
themean and SD of five biological replicates (n= 5), normalized to unstained control. Cell-free conditionedmedium of BMMCs (cultured upon addition of PBS,
100 ng/ml LPS and 0.5 μM A23187) was tested by TRPS with three different pore size membranes (i: NP200 for small EVs, j: NP400 for mEVs and k: NP2000
for lEVs). Graphs show the mean and SD of three independent experiments (n= 3), where one point indicates the average of two technical replicates. e-h: GFP-
BMMC and wild type BMMCs were co-cultured for 24 h. Cells were fixed with 2% PFA, nucleus was stained with DAPI and EV-transfer from GFP-BMMCs
was tested with confocal microscopy (Leica SP8). Cell shapes were visualized by transmitted light. 3D images were generated using LAS X software. Arrows:
Releasing EVs, Arrow heads: EVs
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F IGURE  Immune electron microscopic and TRPS analyses of MC-derived EVs. Particle sizes, size distributions and concentrations of separated large-,
medium size- and small-EVs from the conditioned medium of BMMCs were measured by TRPS using membranes with three different pore sizes (a: NP200
for sEVs, b: NP400 for mEVs and c: NP2000 for lEVs. BMMCs were cultured in the presence of PBS (negative control, blue), LPS (100 ng/ml, red) or A23187
(positive control, green) for 24 h prior to EV separation. Graphs are means of 3 biological replicates with 2-2 technical replicates (n= 6). EVmarkers of BMMC-
derived small (d-f), medium (g-i) and large (j-l) EVs were detected by immunoelectron microscopy using nanogold labelling. PBS (unstimulated): 1st column,
LPS-stimulated: 2nd column, and A23187-stimulated: 3rd column. Gold particles with 10 nm diameter represent CD63 while 5 nm diameter particles indicate
c-Kit
annexinV.Vesicles fromGFP-MCBMMCswere positive forGFP and slightly for lactadherin (Figure 4a, Figure 4b-table). Results
were also confirmed in PCMCs (Figure 4c-table). While there was no difference between LPS-stimulated and unstimulated
groups, A23187-induced EVs which showed an increased fluorescent intensity. In order to decide if lEVs were the results of
apoptosis or not, besides annexin V, we also incubated these EVs with lactadherin, fluorogenic substrate for activated caspase-
3/7 and propidium iodide. There was no significant difference between unstimulated (3.78 ± 2.10%), LPS-stimulated (4.97 ±
3.35%) or A23187-stimulated (4.68 ± 2.52%) mast cell derived lEVs. These results also correlated with viability data of MCs
upon stimulation (annexin V-propidium iodide double negative cells: PBS: 98.27 ± 2.27; LPS: 96.03 ± 2.83; A23187: 9.90 ± 3.10;
Figure S4). EVs were also tested for Alix and TSG101, and medium and sEVs were positive for these proteins by Western blot,
suggesting their exosome content (Figure 4b,d).
For quality control, we also measured lipid and protein contents and calculated protein/lipid ratios. As expected, the pro-
tein/lipid ratio was higher for lEVs (P ≤ 0.01) when compared to mEVs and it was the smallest for sEVs (P ≤ 0.01, t test, Fig-
ure 4e-g).
Density gradient ultracentrifugation was used as a second method for EV isolation. Separated EVs derived from BMMCs
were studied by TRPS and flow cytometry. These EVs showed positivity for lactadherin-binding and for GFP (Figure 4h-j).
Large andmedium sized vesicles showed sensitivity to 0.1% of TritonX-100.Whenwe loaded conditionedmediumon the top of a
density gradient (PCMC, Figure 4k-m) or we used bottom to top density gradient ultracentrifugation of separated EVs (BMMCs,
Figure 4h-j), we got similar results. These EVs were all sensitive to 0.1% Triton X-100 (except for the sEVs) in accordance with
our published data (Osteikoetxea et al., 2015).
. MCs take up EVs from the conditioned media of LPS-stimulated MCs
To confirm that GFP and PKH signal transfer (Figure 2) were due to EV-mediated interactions, we culturedMCs in the presence
of conditioned medium of LPS-stimulated and non-stimulated MCs (Figure 5a). If we depleted the conditioned medium in EVs
before culture, the relative increase of fluorescent intensity of the acceptor cell was lower (GFP:P< 0.05, t test, Figure 5b, PKH:P<
0.01, t test; Figure 5c,d;). We reconstituted the conditioned medium with EVs or we applied EVs in non-conditioned medium to
acceptor MCs. In these cases, the increase in fluorescent intensity was as high as, or even higher than the EV-containing cell-free
supernatant (Figure 5b,c). We confirmed the flow cytometry results also with fluorescent and confocal microscopy (Figure 5e-h).
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F IGURE  Characterization of mast cell-derived EV populations. Large, medium and small EVs derived from 100 ng/ml LPS-stimulated (LPS) or unstim-
ulated (PBS) BMMCs and PCMCs were tested by flow cytometry. A23187 (0.5 μM) was used as positive control. EVs were stained for CD63, CD9 and CD81 or
labelled with fluorochrome-conjugated PKH67, annexin V and lactadherin. GFP expression of EVs derived from C57BL-GFP mice were also measured. Small
EVs were bound onto the surface of aldehyde/sulphate beads (4 μm). Histograms of flow cytometry measurements show single demonstrates of at least three
independent experiments with BMMCs (a, n>3). Tables summarize the results on BMMC (b)-and PCMC (c)-derived EVs. Exosome markers Alix and TSG101
were detected by Western blot on the 3 × 3 EV populations (d). Protein (e) and lipid (f) content of separated EVs were measured by microBCA protein and
SPV lipid assays, respectively. Protein/lipid ratio was also calculated (g). Graphs demonstrate three independent biological replicates (n = 3, *P ≤ 0.05, **P ≤
0.01, t test). An Optiprep gradient was used to further characterize EVs. Separated small, medium and lEVs from the conditioned medium of BMMCs (from
C57BL-GFP) were ultracentrifuged (<16h, 100,000g, 4◦C) bottom up (h-j), while cell-free conditioned medium of PCMCs (from C57BL-GFP) were layered on
the top of an Optiprep gradient (k-m). Particle number was determined by TRPS and their lactadherin binding and positivity for GFP were determined by flow
cytometry. Graphs show means of 3 independent experiments (n = 3)
. LPS stimulated MC-derived EVs induce TNF-α secretion in recipient MCs
In the presence of LPS,MCs secrete TNF-α (Vukman et al., 2012). Here we showed that LPS-stimulated BMMC-derived EVs have
the same effect on naïve, non-stimulatedMCs (Figure 6a) and this effect was dependent on the concentration of EVs (Figure 6b).
If we removed the EVs from the conditioned medium, the TNF-α secretion was lower (P < 0.001) and if we added EVs back
or applied EVs alone, we got the same TNF-α levels (P = 0.40 and P = 0.89, t test, respectively, Figure 6a). We confirmed our
results with more mature PCMC (Figure 6c) as well. Although the drop in TNF-α secretion was not as spectacular as in the case
of BMMCs, it was still significant (P < 0.05, t test). To confirm that our finding was not the result of LPS that adhered onto the
surface of EVs, we incubated EVs in LPS containing medium before co-culture and found no effect on TNF-α secretion (P =
0.80, Figure 6d). All three EV populations seemed to play a role in the induction of TNF-α (lEV: P = 0.31, mEV and sEV<0.05,
Figure 6e). We also used GW4869 a neutral sphingomyelinase inhibitor suggested to interfere with small EV secretion. The
amount of small vesicles decreased (P ≤ 0.05 Figure 6f) in line with published data (Menck et al., 2017). However, there was no
effect of GW4869 on TNF-α secretion (Figure 6g), suggesting that small EVs other than those generated by a ceramide-related
pathway played a role in TNF-α induction.
Since it has been demonstrated earlier that EVs induced TNF-α production in vitro in a TLR4 dependent manner (Couper
et al., 2010), we tested if TLR4 binding or EV uptake were involved in MC activation. We used dynasore and cytochalasin D
to block endocytosis and EV-uptake and TAK242 to inhibit TLR4 signalling. We showed that both processes were important
in EV-MC interaction as pre-treatment of MCs with these inhibitors blocked the effect of LPS-stimulated MC-derived EVs on
naïve (non-stimulated) MCs (P < 0.001, ANOVA, Figure 6h).
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F IGURE  LPS-stimulated mast cell derived extracellular vesicles are taken up by other mast cells. GFP-BMMCs (b) and PKH-stained BMMCs (c, d) were
cultured in EV-free medium in the presence or absence of LPS (100 ng/ml ) for an hour. A23187 (0.5 μM) and PBS were used as positive as negative controls,
respectively. EVs were separated from the conditioned medium after 24 h . Unstained BMMCs derived from C57BL/6 mice were cultured in EV-free medium
(control), conditionedmedium (SN), EV-depleted conditionedmedium (EV-dep SN), EV-reconstructedmedium (EV-rec SN) or separated EVs in freshmedium
(a). EV-uptake was also monitored by confocal microscopy (e-h: GFP (green) merged with DAPI (blue) and lactadherin (red), e: control BMMCs; f: BMMCs
cultured with EVs derived from PBS-stimulated, g: LPS-stimulated and h: A23187-stimulated MCs. The mean of flow cytometric fold increase in MFI values (b,
c) normalized to unstained control of three biological replicates (n= 3, *P≤ 0.05, **P≤ 0.01 t test) are shown. Flow cytometric plots (d) show single demonstrates
of three independent experiments
. MC-derived EVs activate the MAPK signalling pathway
Since we found that TLR4 activation was crucial in EV-mediated TNF-α production, we investigated if the MAPK signalling
pathway was activated during this process. MAPK kinase pathway activation due to TLR4 can result in the phosphorylation of
three central proteins: ERK1/2, JNK and P38 (Avila & Gonzalez-Espinosa, 2011). In our experiments, we showed that the JNK
and P38 pathways were activated, while the ERK1/2 pathway remained inactive (Figure 6i,j).
. MC-derived EVs are taken up by MCs and they induce TNF-α secretion in MCs in vivo in the
peritoneal cavity of mice
We wanted to see if EVs exert the same effect in vivo as in vitro, so we implanted GFP-MC-containing chambers into the peri-
toneal cavity ofmice. In an in vitro experiment, we confirmed that EVs could be released from the chambers whileMCs remained
imprisoned in them (Figure 5, Figure 7l). If MCs were stimulated with LPS before implantation, we detected TNF-α production
in peritoneal lavage MCs (P ≤ 0.05, Figure 7a,d), and these MCs contained GFP-EVs as shown by flow cytometry (P < 0.01,
t test, Figure 7b) and confocal microscopy (Figure 7h-j). For controls, we measured (i) total peritoneal cell numbers, (ii) MC
numbers, (iii) cell viability in the peritoneal cavity and iv) viability of cells retrieved from the removed chambers. We did not
detect significant difference between numbers of MCs (Figure 7c), total peritoneal cells (Figure 7e) and peritoneal cell viability
(Figure 7f) of mice implanted with LPS-stimulated or un-stimulated MC-containing or empty (medium containing) chambers
suggesting that EVs did not inducemigration or proliferation of peritoneal cells and nor did they escape from the chambers. Live
cell retrieval from the chambers was close to 100% (Figure 7g). We also tested if besides MCs, other cell types could also take
up GFP-vesicles released from the implanted chambers. We found an increase in the fluorescence intensity of CD4+ and CD8+
T-cells, B-cells and macrophages increased in the peritoneal cavity (Figure 7k). Regarding the cellular composition of the peri-
toneal cavity, 3.46± 2.07% of the peritoneal cells were T-cells, 24.55± 13.86%were B-cells, 31.30± 13.42%weremacrophages and
1.94 ± 1.06 were MCs (in line with data in the literature (Meurer et al., 2016; Ray & Dittel, 2010; Vasilyev, Yukhneva, Shurygina,
Stukova, & Egorov, 2018)). Out of these cells, 16.48 ± 5.78%, 9.35 ± 0.65%, 12.31 ± 1.81 and 32.59 ± 2.87% of the cells were GFP
positive, respectively. Given that this study focuses onMC-MC communication, in our further experiments we only investigated
MCs.
To exclude the effect of possible residual LPS, we injected LPS in medium (100 ng/ml ) intraperitoneally to mice. This was the
concentration of LPS before the MCs were washed twice prior to implantation. We did not observe a significant increase in the
number and intracellular TNF-α staining of MCs (Figure 6).
We also injected separated BMMC-EVs in bolus into the peritoneal cavity of mice and we analysed the intracellular TNF-α
staining of FcεRI-positive MCs. As shown in Figure 7m, repeated bolus injection of EVs slightly increased the TNF-α content of
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F IGURE  EVs from LPS-stimulatedMCs induce TNF-α secretion in recipientMCs. BMMCs or PCMCswere cultured in EV-freemedium in the presence
or absence of LPS (100 ng/ml ) for an hour. A23187 (0.5 μM) and PBS were used as positive and negative controls, respectively. EVs were separated from the
conditionedmediumafter 24 h.Naïve BMMCs (a) or PCMCs (c)were cultured in EV-freemedium (control) conditionedmedium (SN), EV-depleted conditioned
medium (EV-dep SN), EV-reconstructedmedium (EV-rec SN) or separatedEVcontaining non-conditionedmedium. For concentrationmeasurements, different
ratios of EV donor and acceptor cells were tested (b). Naïve BMMCs were also cultured in the presence of EVs from unstimulated BMMCs incubated in 100
ng/ml LPS for 2 h prior to experiments (d) or large-, medium size- or small-EVs of stimulated and unstimulated MCs (e). We used GW4869 (10 μM), a neutral
sphingomyelinase inhibitor to block small EV generation, 30 min before LPS stimulation of donor cells. As GW4869 was diluted in DMSO, we used DMSO
as control. Separated small particles were measured by NTA (f) and were added to naïve cells (same amount as producing cells) after washing for 24 h (g). In
inhibition experiments, BMMCs were treated with TAK242 (0.2 μM), dynasore (80 μM) cytochalasin D (10μg/ml ) prior to culture in the presence of separated
EVs from conditioned medium of unstimulated (PBS-EV) or LPS-stimulated (LPS-EV) MCs (h). TNF-α concentration was measured after 24 h with ELISA.
Column bars are means of at least three independent experiments (biological replicates, n>3) as the mean and SD of three replicates (n = three, *P ≤ 0.05,
**P ≤ 0.01, t test and ANOVA), where one dot indicates the average of three technical replicates. BMMCs were cultured for 24 h in EV-free complete medium
in the presence of isolated EVs derived from LPS-stimulated (100 ng/ml ) and unstimulated BMMCs. Cells were washed two times lysed and investigated for
phosphorylation of ERK1/2, JNK and P38 by RayBio Cell-based phosphorylation ELISA kits (i). Biological replicates, n≥3, *P ≤ 0.05, **P ≤ 0.01, t test. Schematic
picture shows the possible mechanism of MAPK signalling activation (j)
MCs (P = 0.069, t test) suggesting that EVs may play a role in this activation as MCs were GFP positive (Figure 7n). As in the
case of diffusion chamber experiments, we did not find any difference in the total MC or peritoneal cell numbers (Figure 7o,p).
. LPS-induced EVs have a unique protein content
Although therewas no change in the number andmorphology of LPS-inducedEVs as compared to PBS controls, we hypothesized
that LPS-induced EVs could have an altered protein content. We tested isolated medium sized EVs with mass spectroscopy and
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F IGURE  LPS-stimulated MCs release EVs which spread TNF-α induction in MCs in vivo in the peritoneal cavity of mice. GFP-BMMCs were incubated
for 1h in the presence or absence of LPS (100 ng/ml ). EMDMillipore’s Diffusion Chamber Kits were used with 5 μm pore size membrane filters. Empty (mock-
operated) and MC-containing (100 ng/ml LPS-stimulated or unstimulated) chambers were then implanted to the peritoneal cavities of C57BL/6 mice (a-l). In
additional experiments, EVs separated from the conditionedmedium of LPS-stimulated and unstimulated BMMCswere injected i.p. twice in 24 h (n-p). After 24
h, mice were sacrificed and peritoneal cells were collected by peritoneal lavage. MC numbers (c, o) were determined using Kimura staining by light microscopy
and by flow cytometry using the two pan-MCmarkers CD117 (c-Kit) and FcɛRI. Uptake of EVs by MCs was assessed by flow cytometry based on the GFP signal
(b, n). Peritoneal cells (PC) were counted (e, p) and their viability (f) was assessed by trypan blue staining. Intracellular TNF-α (a, m) was also measured by flow
cytometry after Brefeldin A treatment (3 μg/ml for 1h). Representative plots of intracellular TNF staining in MCs are shown (d). Cells were examined under a
confocal microscope upon staining for FcɛRI expression to identify MC and GFP signal to confirm EV uptake (h: med, i: PBS-MC, j: LPS-MC). Cells retrieved
from the removed diffusion chambers were subjected to enumeration and viability tests using trypan blue staining (live cell recovery is shown in g). EV-uptake
by different cell types including T cells (TC), B cells (BC), macrophages (MP) and mast cells (MC) was determined as the % of GFP+ cells of each cell type (k).
Frequency of different cell types among peritoneal cells (1st row), % of GFP+ cells of each cell type (2nd row) and % of GFP+ cells of a given cell type among all
PCs (3rd row) are summarised in the table below figure k. Graphs show the mean and SD of at least 3 independent experiments (biological replicates, n ≥ 3, *P
≤ 0.05, **P ≤ 0.01, t test). Med: medium, MFI: mean fluorescence intensity
compared mEVs derived from LPS-stimulated MCs and PBS exposed controls. We identified 424 proteins that were present in
both populations, and 12 proteins that were unique to LPS-mEVs (Figure S7A). Among the shared proteins, the amount of 5 pro-
teins were significantly higher in LPS-EVs than in PBS EV-s (P≤ 0.05). These proteins are listed in SuppTable 1, with their poten-
tially relevant biological functions according to NCBI (https://www.ncbi.nlm.nih.gov/) and UniProt (https://www.uniprot.org/)
databases, using Scaffold program. LPS-mEVswere analysed for their origin and functions in biological processes (Figure S7B,C).
We identified 16 proteins with EV localization. Most of the proteins had a biological function (381 from 406 proteins), includ-
ing role in immune processes (91 proteins), signalling (123 proteins) or response to stimuli (257 proteins) (Figure S7C). We also
identified five endogenous TLR4 ligands: HMGB1, heat shock proteins, endoplasmin, myosin S100 A6 presented in MC-derived
EVs (Table S2 (Erridge, 2010, Yu, Wang, & Chen, 2010))
 DISCUSSION
MCs have been long known for their role in allergic reactions as well in the immune defence against bacteria and parasites. More
recently, they have been recognized as orchestrator cells in the immune system being able to regulate many different immune
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processes by the plethora of their stored and secreted bioactive molecules. The biological significance of MCs is strongly under-
lined by the new category of pathological conditions collectively termed as ‘mast cell mediator disorders’ (Theoharides, Tsilioni,
& Ren, 2019). Furthermore,MC proliferation and accumulation results in the disease ‘mastocytosis’ (Kim et al., 2018, Renke et al.,
2019).
MCs are typically localized along epithelia, mucosal membranes and blood vessels. They are key components of innate immu-
nity and play important roles in inflammation. They represent a rich source of the pro-inflammatory mediator TNF-α. MC-
derived TNF-α is required for efficient CD8+ T cell responses to haptens (Dudeck et al., 2015), it promotes the migration and
maturation of CD8+ DCs (Suto et al., 2006), distinctly boosts the CD8+ T-cell-priming efficiency of CD8+ DCs (Krystel-
Whittemore, Dileepan, & Wood, 2015) and promotes Th17 cell–dependent neutrophil recruitment in ovalbumin-challenged
OTII mice (Nakae, Suto, Berry, & Galli, 2007).
We hypothesized that there was amechanism bywhich the relatively low frequencyMCs could amplify their effects and extend
it in space to an entire network of other MCs. We predicted a mechanism by which MCs may send alarming signals and activate
each other in spite of their low frequency to facilitate immune responses. Cytokines and other soluble MC-derived mediators
have been shown to be important in immune cell stimulation in bacterial infections (Mukai, Tsai, Saito, & Galli, 2018). However,
the relatively short lifetime of cytokines limit their effects at distances. In contrast, EVs (increasingly recognized players of cell-
to-cell communication (Vukman et al., 2017)), have been shown to be more stable and may have an effect on MCs in other parts
of the body (Kormelink, Mol, de Jong, & Wauben, 2018, Meldolesi, 2018). In the present study, we investigated MC-derived EVs
for their ability to induce a TNF-α response in other MCs.
Instead of using cell lines, here we analysed the functional consequences of EV release by primary BMMCs and PCMCs in
mice. These primary MCs are more reliable in vitro models than cell lines as the latter may lack some important MC receptors
(e.g. FcƐRI is absent from the MHC mast cell line). Furthermore, MC lines may show characteristics of other cell types as well
(e.g. share molecular features with basophils as observed in the case of RBL-2H3 cells). While BMMCs show higher purity, they
are not as mature as PCMCs. However, these latter cells also have limitations due to their low yield (Yu et al., 2018).
First, we had to confirm that EVs (rather thanmembrane-free granules or solublemediators)mediate communication between
MCs.Although in the literature, the distinction between secretedMCgranules andEVs is often not obvious (Wernersson&Pejler,
2014), MC degranulation can be clearly distinguished fromMC-derived EV release (Kormelink et al., 2016).
By using immunogold electron microscopy, we confirmed the simultaneous presence of c-Kit and CD63 on the isolated small,
medium and large particles, which thus, proved to be MC-derived EV populations. By using flow cytometry, we defined their
surface markers. In addition, we characterized the EV preparations by their total protein and lipid content and their floatation
densities. Finally, we showed that MC-derived EVs were sensitive to detergent lysis, which further proved their vesicular nature.
Thus, we provided evidence that EVs were secreted in vitro by primaryMCs. Furthermore, we demonstrated that the secreted
EVs were transferred fromMCs to MCs and induced TNF-α expression in the recipient resting BMMCs or PCMCs.
To gain an insight into the biogenesis of the MC-derived EVs, first we assessed apoptosis of the releasing MCs to rule out
the possibility that the observed EVs were apoptotic vesicles (Poon et al., 2019). Next, we assessed the presence of TSG101, Alix,
CD63 and CD81 in association with our EVs (Bobrie, Colombo, Krumeich, Raposo, & Théry, 2012, Kowal et al., 2016). Detection
of the above proteins on EVs strongly suggested an endosomal origin of some of our MC-derived EVs. Finally, we used the
neutral sphingomyelinase inhibitor GW4869 to block small EV production (Mariadelva Catalano & O’Driscoll, 2019). While
GW4869 reduced the number of LPS-induced small EVs, it did not interfere with EV transfer and subsequent MC activation.
This suggests that EVs other than those generated by a ceramide-related pathway, might have played a role in the EV-mediated
transfer of MC-MC pro-inflammatory response.
Thus, our data presented in this report, show that EVsmay also play an important role in the antibacterial defence (Piliponsky,
Acharya, & Shubin, 2019) in addition to the de novo produced MCmediators which are well known for being important players
in the defence mechanism against bacteria (Theoharides, Kempuraj, Tagen, Conti, & Kalogeromitros, 2007).
The significance of the above in vitro observed, EV-mediated TNF-α induction could be best evaluated by addressing the
question whether it could be observed also in vivo. To this end, we implanted a disposable device with porous filter walls into the
peritoneal cavity of mice (Nishimura, Uchiyama, Yagi, & Hashimoto, 1985). The implanted chambers contained primary cells,
which could be retrieved after the removal of the device from mice with ∼ 98% viability and close the original cell number after
24 h. Using this implantable devices we showed that MC-derived EVs were taken up by MCs, macrophages, T-cells and B-cells
in line with published data (Vukman et al., 2017). Unexpectedly, we found that MCs were the main acceptor cells of MC-derived
EVs, despite their small cell number (Figure 7h). These results correlate with what is known about MCs that is although they are
present in low numbers in tissues, they play crucial role for example during bacterial infections (Zimmermann et al., 2019) or
sepsis (Echtenacher, Männel, & Hültner, 1996; Piliponsky et al., 2019)).
Importantly, EVs released through the pores of the implanted chamber were not only taken up by peritoneal cells, but they
also induced significant TNF-α expression by peritoneal MCs and were detectable in the cytoplasm of peritoneal lavage MCs by
fluorescent microscopy. In an attempt to reproduce these data, we also injected mice intraperitoneally with bolus injections of
separated EVs from conditionedmedia of GFP-MCs.We found a significant increase in the fluorescence of wild typeMCs in the
peritoneal lavage and a close to significant (P = 0.069, t test) increase in TNF-α production. Clearly, the implantable diffusion
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chamber enabled us to investigate the continuous in vivo release of EVs. The strength of this approach is clearly demonstrated
by the fact that only repeated injections of the separated EVs could recapitulate the effect observed in the case of MCs releasing
EVs continuously from the diffusion chamber.
In this study, we also investigated themechanisms of the cellular uptake ofMC-derived EVs and the induction of the activation
ofMCs by EVs. During bacterial infection, TLR4 is one of the key receptors for innate immune cell activation. In the case ofMCs,
it is known that TLR4 plays a central role in recognition of LPS and bacteria (Supajatura et al., 2002; Vukman et al., 2013 and
Supajatura et al., 2001)). Here we show that MC-derived EVs induce TNF-α production through TLR4, and we identified two
MAPK pathways activated during this process. In addition, given that LPS is a known inducer of oxidative stress in MCs (Aidoo
et al., 2019), and that membrane lipids are defining components of EVs, we hypothesize that oxidized phospholipids of the EV
membrane could have also played a role in TLR4 activation (similarly to what has been described previously (Manček-Keber
et al., 2015)).
Importantly, we found that internalization of EVs by MCs played a key role in MC activation. In the case of bacteria, it has
been reported that their uptake by MCs is a critical factor in the induction of immune responses (cytokine secretion, antigen
presentation, and migration) (Mielcarek et al., 2001; Trivedi et al., 2013). Similarly to bacteria, EVs are also taken up by MCs,
while soluble mediators bind to cell surface receptors. TNFα-induction by naïve MCs exposed to soluble LPS was lower or equal
with what we found upon exposure of MCs to LPS stimulated MC-derived EVs. Internalized EVs have been shown to transfer
molecules to other cells by which they induce activation (Ekström, Valadi, Sjöstrand, Bossios, & Eldh, 2012). Interestingly, Shelke
et al demonstrated that when TGF-β was taken up in association with EVs, it had a prolonged effect on acceptor MCs (Shelke
et al., 2019). In the present study, we found that EVs from stimulatedMCs contained several proteins with known roles in immune
responses (e.g. heat shock protein 70 kDa, H-2 class histocompatibility antigen and tyrosine-protein kinase Fgr) which were not
detected in EVs from unstimulated MCs. We also identified some proteins (such as HMGB1, heat shock proteins, endoplasmin,
myosin, S100 A6 protein) which have been suggested to play a role in endogenous ligand (self-molecule)-induced activation
of TLR 4 (Erridge, 2010, Yu et al., 2010). Given the lack of published evidence for the intracellular/intravesicular presence and
signalling through TLR4, we hypothesize that in our experiments, MC-derived EV-associated TLR4 ligands induced signals via
cell surface TLR4.
In summary, our data presented here prove that bacterial LPS-sensing MCs release EVs that in turn, induce TNF-α in resting
MCs. EV communication between members of the MC network may thus, play an important role in spreading and escalating
pro-inflammatory responses to immune stimuli. Our datamay provide an explanation how the relatively rare and often enigmatic
tissue resident MCs can play key roles in diseases such as autoimmune arthritis, inflammatory bowel disease or Crohn’s disease.
Of note, there are other examples for EVs extending the cellular responses of a relatively small population of cells to other ones
(e.g. dendritic cells extend their antigen presenting capacity to non-primed other dendritic cells (Thery et al., 2002)). Taken
together, the mechanism described in the present report, identifies a novel aspect how MCs of the innate immune system act as
master cells in inflammation and immune responses.
In this study, we only investigated the role of EVs in MC-MC communication. However, the MC-derived EVs may also have
other exciting effects on different other immune and non-immune recipient cells. The in vivo device introduced in this study
may provide a feasible system to investigate many other EV-mediated interactions beyond those described in this paper.
ACKNOWLEDGEMENTS
This work was funded by the Hungarian Scientific Research Fund (OTKA PD112085, 111958 and 120237), the National Heart
Program (NVKP_16-1-2016-0017), VEKOP-2.3.2-16-2017-000002, VEKOP2.3.3-15-2017-00016, H2020-MSCA-ITN-2017-722148
TRAIN EV andHigher Education Excellence Program FIKP, Therapeutic thematic programme). This project has received fund-
ing from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 739593. The first
author was also supported by János Bolyai Research Fellowship of the Hungarian Academy of Sciences.
CONFLICTS OF INTEREST
The authors do not have financial interest to declare.
ORCID
Edit I. Buzás https://orcid.org/0000-0002-3744-206X
REFERENCES
Aidoo, D. B., Obiri, D. D., Osafo, N., Antwi, A. O., Essel, L. B., Duduyemi, B. M., & Ekor, M. (2019). Allergic airway-induced hypersensitivity is attenuated by
bergapten in murine models of inflammation. Advances in Pharmacological Sciences, , 1.
Al-Nedawi, K., Szemraj, J., & Cierniewski, C. S. (2005). Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1,
Arteriosclerosis, Thrombosis, and Vascular Biology, , 1744–1749.
 of  VUKMAN et al.
Amanda Carroll-Portillo, A., Z., Surviladze, Cambi, A., Lidke, D. S., &Wilson, B. S. (2012). Mast cell synapses and exosomes: Membrane contacts for information
exchange, Frontiers in Immunology, (3), 46.
Avila, M., & Gonzalez-Espinosa, C. (2011). Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses, Iubmb Life, (10), 873–
880.
Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., & Théry, C. (2012). Diverse subpopulations of vesicles secreted by different intracellular mechanisms are
present in exosome preparations obtained by differential ultracentrifugation, Journal of Extracellular Vesicles, , 18397.
Couper, K. N., Barnes, T.., Hafalla, J. C., Combes, V., Ryffel, B., Secher, T., … de Souza, J. B., & (2010). Parasite-derived plasma microparticles contribute signifi-
cantly to malaria infection-induced inflammation through potent macrophage stimulation, Plos Pathogens, , e1000744.
Dudeck, J., Ghouse, S. M., Lehmann, C. H., Hoppe, A., Schubert, N., Nedospasov, S. A.,…Dudeck, A. (2015). Mast-cell-derived TNF amplifies CD8(+) dendritic
cell functionality and CD8(+) T cell priming, Cell Reports, , 399–411.
Echtenacher, B., Männel, D. N., & Hültner, L. (1996). Critical protective role of mast cells in a model of acute septic peritonitis, Nature, (6577), 75–77.
Ekström, K., Valadi, H., Sjöstrand, M., Bossios, A., & Eldh, Lötvall J. (2012). Characterization of mRNA and microRNA in human mast cell-derived exosomes
and their transfer to other mast cells and blood CD34 progenitor cells, Journal of Extracellular Vesicles 18389, , 10, 3402.
Ekstrom, K., Valadi, H., Sjostrand, M., Malmhall, C., Bossios, A., Eldh, M., & Lotvall, J. (2012). Characterization of mRNA and microRNA in human mast
cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells, Journal of Extracellular Vesicles, 18389, , 18389-01.
Eldh, M., Ekstrom, K., Valadi, H., Sjostrand, M., Olsson, B., Jernas, M., & Lotvall, J. (2010). Exosomes communicate protective messages during oxidative stress;
possible role of exosomal shuttle RNA, Plos One, , e15353.
Erridge, C. (2010). Endogenous ligands of TLR2 and TLR4: Agonists or assistants? Journal of Leukocyte Biology, (6), 989–999.
Gyorgy, B., Modos, K., Pallinger, E., Paloczi, K., Pasztoi, M., Misjak, P., … Buzas, E. I. (2011). Detection and isolation of cell-derived microparticles are compro-
mised by protein complexes resulting from shared biophysical parameters, Blood, , e39-e48.
Hugle, T., Hogan, V., White, K. E., & van Laar, J. M. (2011). Mast cells are a source of transforming growth factor beta in systemic sclerosis, Arthritis and
Rheumatism, , 795–799.
Kim, D-K., Cho, Y-E., Komarow, H. D., Bandara, G., Song, B-J., Olivera, A., & Metcalfe, D. D. (2018). Mastocytosis-derived extracellular vesicles exhibit a mast
cell signature, transfer KIT to stellate cells, and promote their activation, Proceedings of the National Academy of Sciences of the United States of America,
(45), E10692–E10701.
Kimura, I., Moritani, Y., & Tanizaki, Y. (1973). Basophils in bronchial asthma with reference to reagin-type allergy, Clinical Allergy, , 195–202.
Kormelink, T. G., Arkesteijn, G. J. A., van de Lest, C.H. A., Geerts,W. J. C., Goerdayal, S. S., Altelaar,M. A. F.,…Wauben,M.H.M. (2016).Mast cell degranulation
is accompanied by the release of a selective subset of extracellular vesicles that contain mast cell–specific proteases, Journal of Immunology, (8), 3382–3392.
Kormelink, T. G., Mol, S., de Jong, E. C., &Wauben,M. H.M. (2018). The role of extracellular vesicles when innatemeets adaptive, Seminars in Immunopathology,
, 439–452.
Kowal, J., Arras, G., Colombo,M., Jouve,M.,Morath, J. P., Primdal-Bengtson, B.,…Théry, C. (2016). Proteomic comparison defines novelmarkers to characterize
heterogeneous populations of extracellular vesicle subtypes, Proceedings of the National Academy of Sciences of the United States of America, (8), E968-E977.
Krystel-Whittemore, M., Dileepan, K. N., & Wood, J. G. (2015). Mast cell: A multi-functional master cell, Frontiers in Immunology, , 620.
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